1. Home
  2. STIM vs AXR Comparison

STIM vs AXR Comparison

Compare STIM & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.26

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

Logo AMREP Corporation

AXR

AMREP Corporation

SELL

Current Price

$21.06

Market Cap

111.4M

Sector

Real Estate

ML Signal

SELL

Company Overview

Basic Information
Metric
STIM
AXR
Founded
2003
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Homebuilding
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
120.4M
111.4M
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
STIM
AXR
Price
$1.26
$21.06
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $6.00
N/A
AVG Volume (30 Days)
★ 2.3M
3.9K
Earning Date
11-04-2026
12-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 57.25
N/A
EPS
N/A
★ 0.05
Revenue
★ $52,776,000.00
$12,831,000.00
Revenue This Year
$8.63
N/A
Revenue Next Year
$9.24
$27.27
P/E Ratio
★ N/A
$418.52
Revenue Growth
★ N/A
N/A
52 Week Low
$0.80
$17.61
52 Week High
$3.44
$29.01

Technical Indicators

Market Signals
Indicator
STIM
AXR
Relative Strength Index (RSI) 29.12 48.92
Support Level $1.13 $20.33
Resistance Level $1.61 $21.55
Average True Range (ATR) 0.28 0.66
MACD -0.10 0.06
Stochastic Oscillator 4.59 57.71

Price Performance

Historical Comparison
STIM
AXR

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

About AXR AMREP Corporation

Amrep Corp is engaged in real estate business. The company develops both residential lots and sites for commercial and industrial use as demand warrants. It offers for sale both developed and undeveloped real property to its internal homebuilder as well as national, regional, and local homebuilders, commercial and industrial property developers and others. Activities conducted or arranged by the company include land and site planning, obtaining governmental and environmental approvals, installing utilities and storm drains, ensuring the availability of water service, building or improving roads necessary for land development and constructing community amenities. It also provides landscaping services to homebuilders. It operates in two business segments: land development and homebuilding.

Share on Social Networks: